Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 4
2(50.0%)
N/A
2(50.0%)
4Total
Phase 4(2)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT02963025Not ApplicableCompleted

Protective Ventilation With High Versus Low PEEP During One-lung Ventilation for Thoracic Surgery

Role: collaborator

NCT05089032Completed

The Practice of Providing Palliative Care in the Situation of the COVID-19 Pandemic

Role: collaborator

NCT05877157Recruiting

Pain AND Opioids After Surgery

Role: collaborator

NCT05760339Not ApplicableRecruiting

Intermittent Fasting Versus Carbohydrate Drinks Before Surgery

Role: collaborator

NCT03278548Phase 4Completed

Safety and Efficacy of 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Patients Undergoing Elective Abdominal Surgery

Role: collaborator

NCT05059808Completed

European Sepsis Care Survey

Role: collaborator

NCT04866082Completed

Corticosteroids in Severe COVID-19 (ASAP-ESICM/ESAIC Study)

Role: collaborator

NCT03338218Phase 4Completed

Safety and Efficacy of a 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Trauma Patients

Role: collaborator

All 8 trials loaded